Using telehealth to detect and manage glaucoma in high-risk groups
DP24-081 Novel telehealth technologies to detect and manage glaucoma and vision-threatening eye diseases in high-risk populations
This study is looking at how well telemedicine can help find glaucoma and other eye problems early in Black and Latino communities that may not have easy access to eye care, and it’s inviting people to take part in this important research.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11030179 on NIH RePORTER |
What this research studies
This research investigates the use of telemedicine to screen for glaucoma in populations at high risk, such as Black and Latino individuals. It aims to determine how effective this approach is in detecting glaucoma early, as well as identifying other eye conditions like cataracts or refractive errors. The study will take place at Federally Qualified Health Centers in northern California, where access to eye care is limited. Participants will be randomly assigned to receive telemedicine screening, educational materials, or a delayed intervention.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals from high-risk groups, particularly Black and Latino populations, who may be undiagnosed with glaucoma.
Not a fit: Patients who do not belong to high-risk groups or those who already have diagnosed glaucoma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier detection and management of glaucoma, potentially preventing vision loss in high-risk populations.
How similar studies have performed: Previous research has shown that telemedicine can be effective in screening for various health conditions, suggesting potential success for this novel approach in glaucoma detection.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Keenan, Jeremy David — University of California, San Francisco
- Study coordinator: Keenan, Jeremy David
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.